BACKGROUND: Adverse events are a leading cause of morbidity and mortality. Adverse Drug Events (ADEs) are frequent, under-reported, costly, and largely preventable. Computerized tools expose effectively ADEs and can reduce their impact. METHODS: RADARx is a Veterans Administration (VA) VistA-compatible M software program that integrates computerized ADE screening, probability assessment, documentation, and reporting capabilities. Data dictionary mapping tools have enabled RADARx implementation at 3 sites. All RADARx alerts generated at VA Medical Center (VAMC) Nashville from 7/1/99 to 9/30/99 were evaluated. RESULTS: Total ADEs documented using RADARx numbered 57. RADARx discovered 34 ADEs and 48 'potential' ADEs; 23 ADEs were found using traditional means. Overall, 11% of RADARx alerts were true positives. Pharmacist review of the 8-20 alerts generated daily costs between 10 and 30 minutes.
BACKGROUND: Adverse events are a leading cause of morbidity and mortality. Adverse Drug Events (ADEs) are frequent, under-reported, costly, and largely preventable. Computerized tools expose effectively ADEs and can reduce their impact. METHODS: RADARx is a Veterans Administration (VA) VistA-compatible M software program that integrates computerized ADE screening, probability assessment, documentation, and reporting capabilities. Data dictionary mapping tools have enabled RADARx implementation at 3 sites. All RADARx alerts generated at VA Medical Center (VAMC) Nashville from 7/1/99 to 9/30/99 were evaluated. RESULTS: Total ADEs documented using RADARx numbered 57. RADARx discovered 34 ADEs and 48 'potential' ADEs; 23 ADEs were found using traditional means. Overall, 11% of RADARx alerts were true positives. Pharmacist review of the 8-20 alerts generated daily costs between 10 and 30 minutes.
Authors: A K Jha; G J Kuperman; J M Teich; L Leape; B Shea; E Rittenberg; E Burdick; D L Seger; M Vander Vliet; D W Bates Journal: J Am Med Inform Assoc Date: 1998 May-Jun Impact factor: 4.497
Authors: D W Bates; D J Cullen; N Laird; L A Petersen; S D Small; D Servi; G Laffel; B J Sweitzer; B F Shea; R Hallisey Journal: JAMA Date: 1995-07-05 Impact factor: 56.272
Authors: C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt Journal: Clin Pharmacol Ther Date: 1981-08 Impact factor: 6.875
Authors: R A Raschke; B Gollihare; T A Wunderlich; J R Guidry; A I Leibowitz; J C Peirce; L Lemelson; M A Heisler; C Susong Journal: JAMA Date: 1998-10-21 Impact factor: 56.272
Authors: David W Bates; R Scott Evans; Harvey Murff; Peter D Stetson; Lisa Pizziferri; George Hripcsak Journal: J Am Med Inform Assoc Date: 2003 Mar-Apr Impact factor: 4.497
Authors: Steven M Handler; Richard L Altman; Subashan Perera; Joseph T Hanlon; Stephanie A Studenski; James E Bost; Melissa I Saul; Douglas B Fridsma Journal: J Am Med Inform Assoc Date: 2007-04-25 Impact factor: 4.497
Authors: Alan J Forster; Alison Jennings; Claire Chow; Ciera Leeder; Carl van Walraven Journal: J Am Med Inform Assoc Date: 2012 Jan-Feb Impact factor: 4.497